Antenatal prediction models for short- and medium-term outcomes in preterm infants.


Journal

Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343

Informations de publication

Date de publication:
06 2021
Historique:
revised: 20 02 2021
received: 24 10 2020
accepted: 26 02 2021
pubmed: 4 3 2021
medline: 29 6 2021
entrez: 3 3 2021
Statut: ppublish

Résumé

In extremely and very preterm infants, predicting individual risks for adverse outcomes antenatally is challenging but necessary for risk-stratified perinatal management and parents' participation in decision-making about treatment. Our aim was to develop and validate prediction models for short-term (neonatal period) and medium-term (3 years of age) outcomes based on antenatal maternal and fetal factors alone. A population-based study was conducted on 31 157 neonates weighing ≤1500 g and born between 22 and 31 weeks of gestation registered in the Neonatal Research Network of Japan during 2006-2015. Short-term outcomes were assessed in 31 157 infants and medium-term outcomes were assessed in 13 751 infants among the 31 157 infants. The clinical data were randomly divided into training and validation data sets in a ratio of 2:1. The prediction models were developed by factors selected using stepwise logistic regression from 12 antenatal maternal and fetal factors with the training data set. The number of factors incorporated into the model varied from 3 to 10, on the basis of each outcome. To evaluate predictive performance, the area under the receiver operating characteristics curve (AUROC) was calculated for each outcome with the validation data set. Among short-term outcomes, AUROCs for in-hospital death, chronic lung disease, intraventricular hemorrhage (grade III or IV) and periventricular leukomalacia were 0.85 (95% CI 0.83-0.86), 0.80 (95% CI 0.79-0.81), 0.78 (95% CI 0.75-0.80), and 0.58 (95% CI 0.55-0.61), respectively. Among medium-term outcomes, AUROCs for cerebral palsy and developmental quotient of <70 at 3 years of age were 0.66 (95% CI 0.63-0.69) and 0.72 (95% CI 0.70-0.74), respectively. Although the predictive performance of these models varied for each outcome, their discriminative ability for in-hospital death, chronic lung disease, and intraventricular hemorrhage (grade III or IV) was relatively good. We provided a bedside prediction tool for calculating the likelihood of various infant complications for clinical use. To develop these prediction models would be valuable in each country, and these risk assessment tools could facilitate risk-stratified perinatal management and parents' shared understanding of their infants' subsequent risks.

Identifiants

pubmed: 33656762
doi: 10.1111/aogs.14136
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1089-1096

Informations de copyright

© 2021 Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). Published by John Wiley & Sons Ltd.

Références

Chawanpaiboon S, Vogel JP, Moller A-B, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Global Health. 2019;7:e37-e46.
D'Onofrio BM, Class QA, Rickert ME, Larsson H, Långström N, Lichtenstein P. Preterm birth and mortality and morbidity: a population-based quasi-experimental study. JAMA Psychiatry. 2013;70:1231-1240.
Norman M, Hallberg B, Abrahamsson T, et al. Association between year of birth and 1-year survival among extremely preterm infants in Sweden during 2004-2007 and 2014-2016. JAMA. 2019;321:1188-1199.
Raju TNK, Pemberton VL, Saigal S, Blaisdell CJ, Moxey-Mims M, Buist S. Long-term healthcare outcomes of preterm birth: an executive summary of a conference sponsored by the National Institutes of Health. J Pediatrics. 2017;181:309-318.e1.
Jois RS. Understanding long-term neurodevelopmental outcomes of very and extremely preterm infants: a clinical review. Aust J Gen Pract. 2019;48:26-32.
Lemyre B, Moore G. Counselling and management for anticipated extremely preterm birth. Paediatr Child Health. 2017;22:334-341.
Richardson DK, Zupancic JA, Escobar GJ, Ogino M, Pursley DM, Mugford M. A critical review of cost reduction in neonatal intensive care. II. Strategies for reduction. J Perinatol. 2001;21:121-127.
Mactier H, Bates SE, Johnston T, et al. Perinatal management of extreme preterm birth before 27 weeks of gestation: a framework for practice. Arch Dis Child Fetal Neonatal Ed. 2020;105:232-239.
Tyson JE, Parikh NA, Langer J, Green C, Higgins RD. Intensive care for extreme prematurity-moving beyond gestational age. N Engl J Med. 2008;358:1672-1681.
Rysavy MA, Horbar JD, Bell EF, et al. Assessment of an updated neonatal research network extremely preterm birth outcome model in the Vermont Oxford Network. JAMA Pediatrics. 2020;174:e196294.
Ambalavanan N, Carlo WA, Tyson JE, et al. Outcome trajectories in extremely preterm infants. Pediatrics. 2012;130:e115-e125.
Parry G, Tucker J, Tarnow-Mordi W. CRIB II: an update of the clinical risk index for babies score. Lancet. 2003;361:1789-1791.
Zupancic JA, Richardson DK, Horbar JD, Carpenter JH, Lee SK, Escobar GJ. Revalidation of the score for neonatal acute physiology in the Vermont Oxford Network. Pediatrics. 2007;119:e156-e163.
Podda M, Bacciu D, Micheli A, Bellù R, Placidi G, Gagliardi L. A machine learning approach to estimating preterm infants survival: development of the Preterm Infants Survival Assessment (PISA) predictor. Sci Rep. 2018;8:13743.
Ushida T, Kotani T, Sadachi R, et al. Antenatal corticosteroids and outcomes in preterm twins. Obstet Gynecol. 2020;135:1387-1397.
Watanabe K, Naruse K, Tanaka K, Metoki H, Suzuki Y. Outline of definition and classification of “pregnancy induced hypertension (PIH)”. Hypertens Res Pregnancy. 2013;1:3-4.
Lencki SG, Maciulla MB, Eglinton GS. Maternal and umbilical cord serum interleukin levels in preterm labor with clinical chorioamnionitis. Am J Obstet Gynecol. 1994;170:1345-1351.
Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatrics. 1978;92:529-534.
Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1-7.
Koyama T, Osada H, Tsujii H, Kurita H. Utility of the Kyoto Scale of Psychological Development in cognitive assessment of children with pervasive developmental disorders. Psychiatry Clin Neurosci. 2009;63:241-243.
Kono Y, Yonemoto N, Kusuda S, et al. Developmental assessment of VLBW infants at 18 months of age: a comparison study between KSPD and Bayley III. Brain Dev. 2016;38:377-385.
Sugai MK, Gilmour S, Ota E, Shibuya K. Trends in perinatal mortality and its risk factors in Japan: analysis of vital registration data, 1979-2010. Sci Rep. 2017;7:46681.
Pontello D, Ianni A, Driul L, et al. Prenatal risk factors for intraventricular hemorrhage, neonatal death and impaired psychomotor development in very low birth weight infants. Minerva Ginecol. 2008;60:223-229.
Hatzidaki E, Giahnakis E, Maraka S, et al. Risk factors for periventricular leukomalacia. Acta Obstet Gynecol Scand. 2009;88:110-115.
Daoud JI. Multicollinearity and regression analysis. J Phys Conf Series. 2017;949.
Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
Gee RE, Corry MP. Patient engagement and shared decision making in maternity care. Obstet Gynecol. 2012;120:995-997.
McLeod JS, Menon A, Matusko N, et al. Comparing mortality risk models in VLBW and preterm infants: systematic review and meta-analysis. J Perinatol. 2020;40:695-703.
Garite TJ, Combs CA, Maurel K, et al. A multicenter prospective study of neonatal outcomes at less than 32 weeks associated with indications for maternal admission and delivery. Am J Obstet Gynecol. 2017;217(1):72.e1-72.e9.
Morken NH, Källen K, Jacobsson B. Outcomes of preterm children according to type of delivery onset: a nationwide population-based study. Paed Perinat Epidemiol. 2007;21:458-464.
Milner J, Arezina J. The accuracy of ultrasound estimation of fetal weight in comparison to birth weight: a systematic review. Ultrasound. 2018;26:32-41.
Helenius K, Sjörs G, Shah PS, et al. Survival in very preterm infants: an international comparison of 10 National Neonatal Networks. Pediatrics. 2017;140:e20171264.

Auteurs

Takafumi Ushida (T)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Division of Perinatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan.

Yoshinori Moriyama (Y)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Department of Obstetrics and Gynecology, Fujita Health University School of Medicine, Toyoake, Japan.

Masahiro Nakatochi (M)

Division of Public Health Informatics, Department of Integrative Health Science, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yumiko Kobayashi (Y)

Data Science Division, Data Coordinating Center, Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.

Kenji Imai (K)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Tomoko Nakano-Kobayashi (T)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Noriyuki Nakamura (N)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Masahiro Hayakawa (M)

Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan.

Hiroaki Kajiyama (H)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Tomomi Kotani (T)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Division of Perinatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH